Mark Madden

Title: Mark Madden - Innovator in Association Peptides

Introduction

Mark Madden is a notable inventor based in Davis, CA (US). He has made significant contributions to the field of biochemistry, particularly through his innovative work on association peptides. His research has implications for the development of new molecular structures and therapeutic applications.

Latest Patents

Mark Madden holds a patent for "Association Peptides." This patent describes peptides that form lightly associated homodimers, which can be utilized to create dimers and multimers of other molecules and molecular motifs of interest. The unique aspect of these association peptides is their ability to dimerize regardless of whether motifs are added to the amino-terminus or the carboxy-terminus of the peptide. However, it is important to note that additions to the carboxy-terminus require the presence of certain acidic residues.

Career Highlights

Mark Madden is currently associated with Affymax Technologies, N.V., where he continues to explore the potential of his inventions. His work has positioned him as a key figure in the development of innovative peptide-based solutions.

Collaborations

Throughout his career, Mark has collaborated with esteemed colleagues such as Lois Aldwin and Willem P. Stemmer. These partnerships have fostered a collaborative environment that enhances the research and development of new technologies.

Conclusion

Mark Madden's contributions to the field of association peptides highlight his innovative spirit and dedication to advancing biochemistry. His work not only showcases his expertise but also opens new avenues for research and application in molecular science.